查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498737

放射治療市場，按放射性同位素、方法、應用和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Radiotheranostics Market, By Radioisotope, By Approach, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年放射治療市場規模為 21.152 億美元，2024 年至 2032 年複合年成長率為 14.20%。

放射治療市場-市場動態

癌症盛行率不斷上升推動市場成長

預計隨著癌症發生率的上升，放射治療市場將繼續發展。不受控制地生長的身體細胞擴散到身體的其他部位稱為癌症。當涉及癌症時，用於診斷和治療目的的放射性核素探針被用來以有針對性和選擇性的方式檢測和治療特定的（通常是癌性的）細胞。每個探頭都是根據患者的基本狀況量身定做的，可改善治療結果和效率。這就是放射性核醫超越個人化醫療的方式。例如，根據英國癌症研究組織英國癌症研究中心的數據，2020 年發現了超過 1,800 萬例新癌症病例。此外，預計到 2040 年，全球癌症病例將增加 2,800 萬例，較 2020 年增加 54.9%，與女性（增加 48.8%）相比，這種增加對男性（增加 60.6%）的影響不成比例。因此，放射治療市場受到癌症發生率上升的推動。

放射治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 14.20% 左右的複合年成長率成長

根據方法細分，預計目標治療類別將在 2023 年顯示最大的市場佔有率

從應用細分來看，腫瘤學類別是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

放射治療市場細分分析：

全球放射治療市場根據放射性同位素、方法、應用和區域進行細分。

市場依放射性同位素分為兩類：碘131、碘123、鎵68、鎵177、18F和Y-90等放射性同位素。镥 177 類別在市場上佔據主導地位，這得益於市場上不斷成長的 LU-177 產品使用和可用性。此外，Lu-177 的半衰期比其他治療同位素更長，因此可以實現更長的療程，並可能獲得更好的患者治療效果。例如，Springer 指出 L-177 的物理半衰期為 6.7 天。最近的產品批准和新產品的發布也加速了該領域的成長。此外，諾華於 2022 年 12 月獲得歐盟委員會批准上市 Pluvicto，這是一種靶向放射性配體療法，用於治療前列腺癌。

市場依應用分為以下幾類：腫瘤學（甲狀腺癌、神經內分泌腫瘤、肝細胞癌、攝護腺癌、其他腫瘤學應用）及非腫瘤學（神經系統疾病、關節炎、其他非腫瘤學應用）。腫瘤學類別在市場中佔據主導地位，並可能在預測期內保持其主導地位。這一高比例可以用癌症放射治療產品在太空中廣泛使用這一事實來解釋。此外，新產品的批准、即將推出的產品以及開發尖端成像工具和治療解決方案的不斷變化的需求都預計將推動行業擴張。 Pluvicto、LUTATHERA、AZEDRA 和其他癌症相關治療診斷就是幾個例子。由於醫療保健專業人員對核醫學的偏好，癌症放射治療藥物的有效性有所提高。此外，預計癌症疾病創新核醫學研究支出的增加將支持業務成長。

放射治療市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

在預測期內，預計北美將佔據全球放射治療市場的最大佔有率。對治療性放射性藥物的需求、精準醫療的成長趨勢以及高效成像技術的使用增加正在推動北美放射治療市場的發展。此外，該地區的產業正受到眾多產業參與者及其不同策略努力的推動。例如，2023 年 3 月，Ratio Therapeutics Inc. 宣布已獲得默克公司用於 PET 影像的標靶藥物的許可。

此外，預計亞太地區的放射治療市場將以全球最快的速度擴張。該地區癌症發病率高和核子醫學投資不斷成長是推動該地區市場成長的主要因素。例如，2021 年 3 月，Global Medical Solutions, Ltd. 和 BWXT Medical Ltd. 宣布，他們將合作在亞太地區生產和提供放射性藥物和放射性同位素。亞太地區核子造影方法的增加也促進了市場的採用。

放射治療市場-競爭格局：

Telix Pharmaceuticals Limited.、Novartis AG、IsoTherapeutics Group, LLC、Bayer AG 和 Progenics Pharmaceuticals, Inc.( Lantheus) 等放射治療領域的知名企業正在實施多項戰略措施，以鞏固其地位並保持其地位競爭力。為了改善放射治療技術，他們大力資助研發 (R&D) 項目，這些項目專注於創造新型放射性藥物、增強顯像劑和擴大治療潛力。為了獲取資源、交流知識和利用專業知識，他們正在與學術機構、研究中心和其他產業參與者結盟。此外，行業領導者之間的合作夥伴關係使企業能夠提高產品品質、擴大客戶群並加快新產品的開發。

最近的發展：

2023 年 3 月：Pharma 15 Corporation 是一家總部位於美國的公司，專注於開發用於前列腺癌的尖端治療放射性藥物，已被 Radiopharm Theranostics 收購。透過這項精心策劃的舉措，Radiopharm Theranostics 能夠獲得前列腺癌治療方面的尖端技術和知識，從而擴大其產品組合併鞏固其在放射治療行業的地位。

2023 年 6 月：Thor Medical 是一家年輕的製造商，生產用於治療癌症的放射性藥物的 α 發射體，被 Nordic Nanovector 收購。透過整合 Thor Medical 的知識和 α 發射器技術，這項經過深思熟慮的舉措增強了 Nordic Nanovector 的能力，使其產品線多樣化，並鞏固了其在癌症市場的地位。

目錄

第1章：放射治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 放射治療市場片段（按放射性同位素）
    • 按方法分類的放射治療市場摘要
    • 按應用分類的放射治療市場片段
    • 按國家/地區分類的放射治療市場摘要
    • 按地區分類的放射治療市場摘要
  • 競爭洞察

第 3 章：放射治療主要市場趨勢

  • 放射治療市場促進因素
    • 市場促進因素的影響分析
  • 放射治療市場限制
    • 市場限制影響分析
  • 放射治療市場機會
  • 放射治療市場未來趨勢

第 4 章：放射治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：放射治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：放射治療市場格局

  • 2023 年放射治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：放射治療市場 - 按放射性同位素

  • 概述
    • 按放射性同位素分類的細分市佔率分析
    • 碘131
    • 洛丁-123
    • 鎵68
    • 镥177
    • 18F 配備 Y-90
    • 其他放射性同位素

第 8 章：放射治療市場 - 依方法

  • 概述
    • 按方法分類的細分市場佔有率分析
    • 標靶治療
    • 針對性診斷

第 9 章：放射治療市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 腫瘤學
      • 甲狀腺癌
      • 神經內分泌腫瘤
      • 肝細胞癌
      • 攝護腺癌
      • 其他腫瘤學應用
    • 非腫瘤學
      • 神經系統疾病
      • 關節炎
      • 其他非腫瘤學應用

第 10 章：放射治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美放射治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美洲市場規模與預測（按放射性同位素）
    • 北美市場規模和預測（按方法）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲放射治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲放射性同位素市場規模與預測
    • 歐洲市場規模與預測（按方法）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區放射治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區放射性同位素市場規模與預測
    • 亞太地區市場規模與預測（依方法）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲放射治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按放射性同位素）
    • 拉丁美洲市場規模與預測（按方法）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲放射治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按放射性同位素）
    • 中東和非洲市場規模及預測（依方法）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 放射治療產業

  • 競爭儀表板
  • 公司簡介
    • Telix Pharmaceuticals Limited.
    • Novartis AG
    • IsoTherapeutics Group, LLC
    • Bayer AG
    • Progenics Pharmaceuticals, Inc.( Lantheus)
    • ITM Radiopharma
    • Q BioMed Inc.
    • Life Molecular Imaging
    • RadioMedix
    • Nordic Nanovector ASA
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2906

REPORT HIGHLIGHT

Radiotheranostics Market size was valued at USD 2,115.2 Million in 2023, expanding at a CAGR of 14.20% from 2024 to 2032.

Radiotheranostics is a new area of medicine that combines the use of radiopharmaceuticals for both therapeutic and diagnostic purposes. It includes the simultaneous diagnosis and treatment of illnesses with the use of radiotracers, which are molecules tagged with radioactive isotopes. It involves using single-photon emission computed tomography (SPECT) or positron emission tomography (PET) imaging to see particular molecular targets or biomarkers within the body. Giving comprehensive details regarding the location and severity of the disease facilitates accurate and customized diagnosis. The therapeutic component entails applying the same radiotracer or a comparable substance to give targeted radiation therapy directly to the site of sickness.

Radiotheranostics Market- Market Dynamics

Growing Cancer Prevalence to Propel Market Growth

It is anticipated that the market for radiotheranostics will continue to develop as cancer incidence rises. Uncontrollably growing body cells that spread to other parts of the body are known as cancerous conditions. When it comes to cancer, radionuclide probes that are paired for both diagnostic and therapeutic purposes are used to detect and treat specific (usually cancerous) cells in a targeted and selective manner. Each probe is tailored to the patient's underlying condition, improving treatment outcomes and efficiency. This is how radionuclide medicine goes beyond personalized medicine. For instance, over 18 million new instances of cancer were discovered in 2020, according to Cancer Research UK, a UK-based cancer research organization. Furthermore, it is projected that by 2040, there will be 28 million additional instances of cancer worldwide, a 54.9% rise from 2020 and that this increase would disproportionately affect men (60.6% increase) compared to women (48.8% increase). Consequently, the market for radiotheranostics is driven by the rising incidence of cancer.

Radiotheranostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.20% over the forecast period (2024-2032)

Based on approach segmentation, the targeted therapeutic category was predicted to show maximum market share in the year 2023

Based on application segmentation, the oncology category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Radiotheranostics Market- Segmentation Analysis:

The Global Radiotheranostics Market is segmented on the basis of Radioisotope, Approach, Application, and Region.

The market is divided into two categories based on radioisotope: Iodine-131, lodine-123, Gallium-68, Lutetium-177, 18F with Y-90, and Other radioisotopes. The lutetium-177 category dominates the market, which is fueled by the market's growing LU-177 product usage and availability. Furthermore, Lu-177 has a longer half-life than other therapeutic isotopes, allowing for a longer course of treatment and possibly better patient outcomes. For instance, Springer states that L-177 has a 6.7-day physical half-life. Recent product approvals and fresh releases have also accelerated the segment's growth. Moreover, Novartis was granted European Commission approval in December 2022 to market Pluvicto, a targeted radioligand therapy, for the treatment of prostate cancer.

The market is divided into the following categories based on application: Oncology (Thyroid cancer, Neuroendocrine tumors, Hepatocellular carcinoma, Prostate cancer, Other oncology applications) and Non-oncology (Neurological disorders, Arthritis, Other non-oncology applications). The oncology category dominates the market and is likely to maintain its dominance during the forecast period. This high percentage can be explained by the fact that cancer radiotheranostics items are widely available in space. Furthermore, new product approvals, impending product launches, and the changing need for developing cutting-edge imaging tools and treatment solutions are all projected to fuel industry expansion. Pluvicto, LUTATHERA, AZEDRA, and other cancer-related theranostics are a few examples. The effectiveness of cancer radiotheranostic drugs has increased due to healthcare professionals' preference for nuclear medicine. Furthermore, it is anticipated that rising research expenditures in innovative nuclear medicine for cancer disorders will support business growth.

Radiotheranostics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for radiotheranostics. The market for radiotheranostics in North America is being pushed by the demand for therapeutic radiopharmaceuticals, a growing trend towards precision medicine, and the increased usage of efficient imaging technologies. Moreover, the sector in the area is being driven by a multiplicity of industrial actors and their different strategic endeavours. For example, in March 2023, Ratio Therapeutics Inc. announced that it has licenced a Merck targeted medication used in PET imaging.

In addition, the radiotheranostics market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The high cancer prevalence in the area and growing nuclear medicine investments are the main factors propelling the growth of the regional market. For instance, in March 2021, Global Medical Solutions, Ltd. and BWXT Medical Ltd. announced that they will be working together to produce and provide radiopharmaceuticals and radioisotopes across the Asia Pacific region. An increase in nuclear imaging methods in Asia Pacific is also contributing to the market adoption.

Radiotheranostics Market- Competitive Landscape:

Several strategic measures are being implemented by prominent players such as Telix Pharmaceuticals Limited., Novartis AG, IsoTherapeutics Group, LLC, Bayer AG, and Progenics Pharmaceuticals, Inc.( Lantheus), among others in the radiotheranostics sector to fortify their position and maintain their competitiveness. To improve radiotheranostics technologies, they are heavily funding research and development (R&D) projects that concentrate on creating novel radiopharmaceuticals, enhancing imaging agents, and expanding therapeutic potential. To gain access to resources, exchange knowledge, and capitalize on expertise, they are forming alliances with academic institutions, research centers, and other industry participants. Furthermore, partnerships among industry leaders enable businesses to improve the caliber of their products, broaden their customer base, and expedite the creation of new products.

Recent Developments:

March 2023: Pharma 15 Corporation, a US-based business focused on creating cutting-edge therapeutic radiopharmaceuticals for prostate cancer, has been acquired by Radiopharm Theranostics. Through this calculated move, Radiopharm Theranostics was able to expand its portfolio and solidify its position in the radiotheranostics industry by gaining access to cutting-edge technology and knowledge in the treatment of prostate cancer.

June 2023: Thor Medical, a young manufacturer of alpha-emitters for radiopharmaceuticals intended to cure cancer, was acquired by Nordic Nanovector. By incorporating Thor Medical's knowledge and alpha-emitter technology, this calculated move strengthened Nordic Nanovector's capabilities, diversifying its product line and solidifying its position in the cancer market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RADIOTHERANOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Telix Pharmaceuticals Limited.

Novartis AG

IsoTherapeutics Group, LLC

Bayer AG

Progenics Pharmaceuticals, Inc.( Lantheus)

ITM Radiopharma

Q BioMed Inc.

Life Molecular Imaging

RadioMedix

Nordic Nanovector ASA

Others

GLOBAL RADIOTHERANOSTICS MARKET, BY RADIOISOTOPE- MARKET ANALYSIS, 2019 - 2032

  • Iodine-131
  • lodine-123
  • Gallium-68
  • Lutetium-177
  • 18F with Y-90
  • Other radioisotopes

GLOBAL RADIOTHERANOSTICS MARKET, BY APPROACH- MARKET ANALYSIS, 2019 - 2032

  • Targeted therapeutic
  • Targeted diagnostic

GLOBAL RADIOTHERANOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Thyroid cancer
  • Neuroendocrine tumors
  • Hepatocellular carcinoma
  • Prostate cancer
  • Other oncology applications
  • Non-oncology
  • Neurological disorders
  • Arthritis
  • Other non-oncology applications

GLOBAL RADIOTHERANOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Radiotheranostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Radiotheranostics Market Snippet by Radioisotope
    • 2.1.2. Radiotheranostics Market Snippet by Approach
    • 2.1.3. Radiotheranostics Market Snippet by Application
    • 2.1.4. Radiotheranostics Market Snippet by Country
    • 2.1.5. Radiotheranostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Radiotheranostics Key Market Trends

  • 3.1. Radiotheranostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Radiotheranostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Radiotheranostics Market Opportunities
  • 3.4. Radiotheranostics Market Future Trends

4. Radiotheranostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Radiotheranostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Radiotheranostics Market Landscape

  • 6.1. Radiotheranostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Radiotheranostics Market - By Radioisotope

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Radioisotope, 2023 & 2032 (%)
    • 7.1.2. Iodine-131
    • 7.1.3. lodine-123
    • 7.1.4. Gallium-68
    • 7.1.5. Lutetium-177
    • 7.1.6. 18F with Y-90
    • 7.1.7. Other radioisotopes

8. Radiotheranostics Market - By Approach

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Approach, 2023 & 2032 (%)
    • 8.1.2. Targeted therapeutic
    • 8.1.3. Targeted diagnostic

9. Radiotheranostics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Oncology
      • 9.1.2.1. Thyroid cancer
      • 9.1.2.2. Neuroendocrine tumors
      • 9.1.2.3. Hepatocellular carcinoma
      • 9.1.2.4. Prostate cancer
      • 9.1.2.5. Other oncology applications
    • 9.1.3. Non-oncology
      • 9.1.3.1. Neurological disorders
      • 9.1.3.2. Arthritis
      • 9.1.3.3. Other non-oncology applications

10. Radiotheranostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Radiotheranostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Radiotheranostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Radiotheranostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Radiotheranostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Radiotheranostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Radiotheranostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Telix Pharmaceuticals Limited.
    • 11.2.2. Novartis AG
    • 11.2.3. IsoTherapeutics Group, LLC
    • 11.2.4. Bayer AG
    • 11.2.5. Progenics Pharmaceuticals, Inc.( Lantheus)
    • 11.2.6. ITM Radiopharma
    • 11.2.7. Q BioMed Inc.
    • 11.2.8. Life Molecular Imaging
    • 11.2.9. RadioMedix
    • 11.2.10. Nordic Nanovector ASA
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Radiotheranostics Market: Radioisotope Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Radioisotope
  • TABLE Global Radiotheranostics Market, by Radioisotope 2019-2032 (USD Million)
  • TABLE Radiotheranostics Market: Approach Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Approach
  • TABLE Global Radiotheranostics Market, by Approach 2019-2032 (USD Million)
  • TABLE Radiotheranostics Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Radiotheranostics Market, by Application 2019-2032 (USD Million)
  • TABLE Radiotheranostics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Radiotheranostics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE North America Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Europe Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Asia Pacific Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Latin America Radiotheranostics Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Radiotheranostics Market, by Application, 2019-2032 (USD Million)